Calidi Biotherapeutics, Inc. (CLDI)
USD 1.44
(-16.76%)
USD 1.44
(-16.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -26.98 Million | -13.21 Million | -1.08 Million | -4.82 Million |
| Net Income | -29.21 Million | -25.42 Million | 3.38 Million | -7.93 Million |
| Depreciation & Amortization | 1.25 Million | 260 Thousand | 153 Thousand | 117 Thousand |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 4.8 Million | 6.14 Million | 1.32 Million | 968 Thousand |
| Change in working capital | -6.24 Million | 3.56 Million | -290.86 Thousand | 945 Thousand |
| Other non-cash items | 15.9 Million | 7.28 Million | -4.24 Million | 77 Thousand |
| Investing Cash Flow | -478 Thousand | -494 Thousand | -230 Million | -388 Thousand |
| Investments in PPE | -585 Thousand | -428 Thousand | -206 Thousand | -351 Thousand |
| Acquisitions | 9000.00 | - | - | - |
| Investment purchases | - | - | -230 Million | - |
| Sales/Maturities of investments | - | 190.01 Million | - | - |
| Other Investing Activities | 107 Thousand | -66 Thousand | -9000.00 | -37 Thousand |
| Financing Cash Flow | 29.04 Million | 12.08 Million | 232.14 Million | 4.69 Million |
| Debt repayment | -899 Thousand | -1.38 Million | -1.75 Million | -1.87 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | -175 Thousand |
| Common Stock Issuance | 30.3 Million | 10.76 Million | 232.78 Million | 2.99 Million |
| Other Financing Activities | 604 Thousand | 10.59 Million | -640.12 Thousand | -4000.00 |
| Accounts receivables | - | -870.00 | - | - |
| Accounts payables | -6.17 Million | 1.62 Million | 63.83 Thousand | 293 Thousand |
| Inventory | - | - | - | - |
| Other working capital | -72 Thousand | 1.94 Million | -354.7 Thousand | 652 Thousand |
| Cash at beginning of period | 472 Thousand | 1.06 Million | 420 Thousand | 934 Thousand |
| Cash at end of period | 2.04 Million | 472 Thousand | 1.06 Million | 420 Thousand |
| Capital Expenditure | -585 Thousand | -428 Thousand | -206 Thousand | -351 Thousand |
| Effect of forex changes on cash | -6000.00 | -26 Thousand | -4000.00 | 3000.00 |
| Net cash flow / Change in cash | 1.57 Million | -590.65 Thousand | 642.65 Thousand | -514 Thousand |
| Free Cash Flow | -27.56 Million | -13.64 Million | -1.28 Million | -5.17 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.22 Million | -8.22 Million | -29.21 Million | -2.02 Million | -4.26 Million | -2.22 Million |
| Depreciation & Amortization | 374 Thousand | 364 Thousand | 1.25 Million | 100 Thousand | 364 Thousand | 183 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 888 Thousand | 1.18 Million | 4.8 Million | 1.1 Million | 1.08 Million | 1.43 Million |
| Change in working capital | 1.91 Million | 2.98 Million | -6.24 Million | -12.55 Million | 1.46 Million | 1.86 Million |
| Other non-cash items | 883 Thousand | 418.99 Thousand | 15.9 Million | -7.69 Million | 3.18 Million | 555.7 Thousand |
| Investing Cash Flow | -5000.00 | -35 Thousand | -478 Thousand | 277.3 Thousand | -294.45 Thousand | -425.85 Thousand |
| Investments in PPE | -5000.00 | -70 Thousand | -585 Thousand | -515 Thousand | -306 Thousand | -137 Thousand |
| Acquisitions | - | - | 9000.00 | 9000.00 | - | - |
| Investment purchases | - | - | - | 1.34 Million | -916.74 Thousand | -425.85 Thousand |
| Sales/Maturities of investments | - | - | - | -622.28 Thousand | 622.28 Thousand | - |
| Other Investing Activities | - | 35 Thousand | 107 Thousand | 72 Thousand | 63 Thousand | - |
| Financing Cash Flow | 3.01 Million | -2.95 Million | 29.04 Million | 31.27 Million | 500 Thousand | 222.5 Thousand |
| Debt repayment | -3.03 Million | -802 Thousand | -899 Thousand | -978.5 Thousand | -500 Thousand | -222.5 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 30.3 Million | 30.3 Million | - | - |
| Other Financing Activities | -162 Thousand | -660 Thousand | 604 Thousand | 21.65 Million | 6.59 Million | 1.27 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 968 Thousand | 1.48 Million | -6.17 Million | - | - | 21 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 949 Thousand | 9.15 Million | -72 Thousand | -12.55 Million | 1.46 Million | 1.86 Million |
| Cash at beginning of period | 2.04 Million | 10.24 Million | 472 Thousand | 669.86 Thousand | 82.82 Thousand | 93.89 Thousand |
| Cash at end of period | 1.24 Million | 2.04 Million | 2.04 Million | 10.24 Million | 669.86 Thousand | 82.82 Thousand |
| Capital Expenditure | -5000.00 | -70 Thousand | -585 Thousand | -515 Thousand | -306 Thousand | -137 Thousand |
| Effect of forex changes on cash | 17 Thousand | -19 Thousand | -6000.00 | 23 Thousand | -10 Thousand | - |
| Net cash flow / Change in cash | -806 Thousand | -8.19 Million | 1.57 Million | 9.57 Million | 587.03 Thousand | -11.06 Thousand |
| Free Cash Flow | -3.83 Million | -5.25 Million | -27.56 Million | -22.88 Million | 75.49 Thousand | 55.28 Thousand |
APPF
0TIQ
HSTA
RRDMF
TOUP
6936